TD Asset Management Inc. increased its position in shares of Tilray Inc (NASDAQ:TLRY – Get Rating) by 21.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,057,634 shares of the company’s stock after purchasing an additional 187,469 shares during the period. TD Asset Management Inc. owned 0.17% of Tilray worth $3,008,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Public Sector Pension Investment Board grew its stake in shares of Tilray by 3.8% during the second quarter. Public Sector Pension Investment Board now owns 1,228,067 shares of the company’s stock worth $3,818,000 after purchasing an additional 44,787 shares in the last quarter. Vontobel Holding Ltd. grew its stake in shares of Tilray by 35.2% during the third quarter. Vontobel Holding Ltd. now owns 249,748 shares of the company’s stock worth $687,000 after purchasing an additional 65,002 shares in the last quarter. State of New Jersey Common Pension Fund D grew its stake in shares of Tilray by 16.0% during the second quarter. State of New Jersey Common Pension Fund D now owns 481,295 shares of the company’s stock worth $1,502,000 after purchasing an additional 66,322 shares in the last quarter. Traynor Capital Management Inc. grew its stake in shares of Tilray by 41.5% during the second quarter. Traynor Capital Management Inc. now owns 22,521 shares of the company’s stock worth $70,000 after purchasing an additional 6,609 shares in the last quarter. Finally, Coastal Investment Advisors Inc. acquired a new position in Tilray in the third quarter valued at $28,000. Institutional investors and hedge funds own 11.59% of the company’s stock.
Analyst Ratings Changes
TLRY has been the subject of several research analyst reports. Sanford C. Bernstein initiated coverage on shares of Tilray in a research note on Tuesday, November 1st. They issued a “market perform” rating and a $3.90 price objective for the company. Haywood Securities decreased their price objective on shares of Tilray to $3.50 in a research note on Thursday, October 13th. Alliance Global Partners decreased their price objective on shares of Tilray from $4.00 to $3.00 and set a “neutral” rating for the company in a research note on Monday, January 9th. Finally, Cantor Fitzgerald upped their price objective on shares of Tilray from $4.15 to $4.50 and gave the company a “neutral” rating in a research note on Monday, October 10th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $5.08.
Tilray Stock Down 4.5 %
NASDAQ TLRY opened at $3.20 on Monday. Tilray Inc has a 52-week low of $2.52 and a 52-week high of $9.08. The firm has a 50-day moving average price of $3.22 and a 200 day moving average price of $3.43. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.91 and a quick ratio of 1.35.
Tilray (NASDAQ:TLRY – Get Rating) last posted its quarterly earnings results on Monday, January 9th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.01). The firm had revenue of $144.10 million for the quarter, compared to analysts’ expectations of $157.21 million. Tilray had a negative return on equity of 5.10% and a negative net margin of 89.96%. Tilray’s quarterly revenue was down 7.1% compared to the same quarter last year. On average, equities research analysts predict that Tilray Inc will post -0.34 earnings per share for the current fiscal year.
Tilray Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.